Skip to main content
SpringerLink
Log in

XIAP: Apoptotic brake and promising therapeutic target

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

The X-linked Inhibitor of Apoptosis, XIAP, is a key member of the newly discovered family of intrinsic inhibitors of apoptosis (IAP) proteins. IAPs block cell death both in vitro and in vivo by virtue of inhibition of distinct caspases. Although other proteins have been identified which inhibit upstream caspases, only the IAPs have been demonstrated to be endogenous repressors of the terminal caspase cascade. In turn, the caspase inhibiting activity of XIAP is negatively regulated by at least two XIAP-interacting proteins, XAF1 and Smac/DIABLO. In addition to the inhibition of caspases, recent discoveries from several laboratories suggest that XIAP is also involved in a number of other biologically significant cellular activities including modulation of receptor-mediated signal transduction and protein ubiquitination. XIAP is also translated by a rare cap-independent mechanism mediated by a specific sequence called IRES (for Internal Ribosome Entry Site) which is found in the XIAP 5′ UTR. XIAP protein is thus synthesized under various conditions of cellular stress such as serum starvation and low dose γ-irradiation induced apoptosis, conditions that lead to the inhibition of cellular protein synthesis. The multiple biological activities of XIAP, its unique translational and post-translational control and the centrality of the caspase cascade make the control of XIAP expression an exceptionally promising molecular target for modulating apoptosis. Therapeutic benefits can be derived from both the suppression of inappropriate cell death such as in neurodegenerative disorders and ischemic injury or in the activation of latent cell death pathways such as in autoimmune disease and cancer where apoptosis induction is the desired outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Birnbaum MJ, Clem RJ, Miller LK. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J Virol 1994; 68: 2521-2528.

    Google Scholar 

  2. Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 1993; 67: 2168-2174.

    Google Scholar 

  3. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247-3259.

    Google Scholar 

  4. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13: 239-252.

    Google Scholar 

  5. Kasof GM, Gomes BC. Livin, a novel inhibitor-of-apoptosis (IAP) family member. J Biol Chem 2001; 276: 3238-3246.

    Google Scholar 

  6. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300-304.

    Google Scholar 

  7. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. Embo J 1997; 16: 6914-6925.

    Google Scholar 

  8. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. Embo J 1999; 18: 5242-5251.

    Google Scholar 

  9. Deveraux QL, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. Embo J 1998; 17: 2215-2223.

    Google Scholar 

  10. Sun C, et al. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 1999; 401: 818-822.

    Google Scholar 

  11. Sun C, et al. NMR structure and mutagenesis of the third bir domain of the inhibitor of apoptosis protein XIAP. J Biol Chem 2000; 275: 33777-33781.

    Google Scholar 

  12. Hinds MG, Norton RS, Vaux DL, Day CL. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol 1999; 6: 648-651.

    Google Scholar 

  13. Takahashi R, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998; 273: 7787-7790.

    Google Scholar 

  14. Johnson DE, et al. Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis. Cancer Res 2000; 60: 1818-1823.

    Google Scholar 

  15. Freemont PS, Hanson IM, Trowsdale J. A novel cysteine-rich sequence motif. Cell 1991; 64: 483-484.

    Google Scholar 

  16. Borden KL. RING domains: Master builders of molecular scaffolds? J Mol Biol 2000; 295: 1103-1112.

    Google Scholar 

  17. Joazeiro CA, Weissman AM. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 2000; 102: 549-552.

    Google Scholar 

  18. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems. Nat Cell Biol 2000; 2: E153-E157.

    Google Scholar 

  19. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM, Osborne BA. Proteasomes play an essential role in thymocyte apoptosis. Embo J 1996; 15: 3835-3844.

    Google Scholar 

  20. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000; 288: 874-877.

    Google Scholar 

  21. Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 2000; 275: 26661-26664.

    Google Scholar 

  22. Liston P, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379: 349-353.

    Google Scholar 

  23. Kozak M. The scanning model for translation: An update. J Cell Biol 1989; 108: 229-241.

    Google Scholar 

  24. Holcik M, Lefebvre CA, Yeh C, Chow T, Korneluk RG. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nature Cell Biology 1999; 1: 190-192.

    Google Scholar 

  25. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988; 334: 320-325.

    Google Scholar 

  26. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. A segment of the 5? nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988; 62: 2636-2643.

    Google Scholar 

  27. Holcik M, Sonenberg N, Korneluk RG, Internal ribosome initiation of translation and the control of cell death. Trends in Genetics 2000; 16: 469-473.

    Google Scholar 

  28. Holcik M, Yeh C, Korneluk RG, Chow T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 2000; 19: 4174-4177.

    Google Scholar 

  29. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70: 113-122.

    Google Scholar 

  30. Liston P, et al. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nature Cell Biology 2001; 3: 128-133.

    Google Scholar 

  31. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.

    Google Scholar 

  32. Verhagen AM, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102: 43-53.

    Google Scholar 

  33. Chai J, Du C, Wu JW, Kyin S, Wang X, Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000; 406: 855-862.

    Google Scholar 

  34. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 2000; 275: 36152-36157.

    Google Scholar 

  35. Wu G, et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 2000; 408: 1008-1012.

    Google Scholar 

  36. Liu Z, et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 2000; 408: 1004-1008.

    Google Scholar 

  37. Yamaguchi K, et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. Embo J 1999; 18: 179-187.

    Google Scholar 

  38. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.

    Google Scholar 

  39. Sanna MG, Duckett CS, Richter BW, Thompson CB, Ulevitch RJ. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc Natl Acad Sci USA 1998; 95: 6015-6020.

    Google Scholar 

  40. Takatsu Y, et al. TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development. Mol Cell Biol 2000; 20: 3015-3026.

    Google Scholar 

  41. Xu D, et al. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci 1999; 19: 5026-5033.

    Google Scholar 

  42. Kugler S, Straten G, Kreppel F, Isenmann S, Liston P, Bahr M. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 2000; 7: 815-824.

    Google Scholar 

  43. Tamm I, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 2000; 6: 1796-1803.

    Google Scholar 

  44. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 2000; 60: 5659-5666.

    Google Scholar 

  45. Chai J, et al. Structural basis of caspase-7 inhibition by XIAP. Cell 2001; 104: 769-780.

    Google Scholar 

  46. Huang Y, et al. Structural basis of caspase inhibition by XIAP. Differential roles of the linker versus the BIR domain. Cell 2001; 104: 781-790.

    Google Scholar 

  47. Riedl SJ, et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001; 104: 791-800.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ægera Oncology, Inc., and Solange Gauthier-Karsh Molecular Genetics Laboratory, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada

    Martin Holcik & Hilary Gibson

  2. Ægera Oncology, Inc., and Solange Gauthier-Karsh Molecular Genetics Laboratory, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada

    Robert G. Korneluk

Authors
  1. Martin Holcik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hilary Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert G. Korneluk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holcik, M., Gibson, H. & Korneluk, R.G. XIAP: Apoptotic brake and promising therapeutic target. Apoptosis 6, 253–261 (2001). https://doi.org/10.1023/A:1011379307472

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011379307472

Search

Navigation